Ajmaline: Difference between revisions
No edit summary |
No edit summary |
||
| (9 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
{{drugbox | | {{drugbox | | ||
| IUPAC_name = | | IUPAC_name =(17''R'',21β)-ajmalan-17,21-diol<br />OR<br />(1''R'',9''R'',10''S'',13''R'',14''R'',16''S'',18''S'')-13-ethyl-8-methyl-8,15-diazahexacyclo[14.2.1.0<sup>1,9</sup>.0<sup>2,7</sup>.0<sup>10,15</sup>.0<sup>12,17</sup>]nonadeca-2(7),3,5-triene-14,18-diol | ||
| image = Ajmaline_svg.png | | image = Ajmaline_svg.png | ||
| CAS_number = 4360-12-7 | | CAS_number = 4360-12-7 | ||
| Line 24: | Line 24: | ||
}} | }} | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Ajmaline''' is a class Ia [[antiarrhythmic agent]]. It is often used to | '''Ajmaline''' is a class Ia [[antiarrhythmic agent]]. It is often used to bring out typical findings of ST elevations in patients suspected of having [[Brugada syndrome]]. | ||
The compound was first isolated by [[Salimuzzaman Siddiqui]] in 1931 <ref>Siddiqui, S. & Siddiqui, R.H. (1931). Journal of the Indian Chemical Society, vol. 8, pp. 667-680.</ref> from the roots of [[Rauwolfia serpentina]]. He named it [[Ajmaline]], after [[Hakim Ajmal Khan]], one of the most illustrious practitioners of [[Unani|Unani system of medicine]] in South Asia.<ref name="sandilvi">Ahmed Nasim Sandilvi (2003), [http://www.dawn.com/weekly/science/archive/030412/science5.htm Salimuzzaman Siddiqui: pioneer of scientific research in Pakistan]. Daily Dawn. 12 April, 2003. Retrieved on 19 July, 2007.</ref> | The compound was first isolated by [[Salimuzzaman Siddiqui]] in 1931 <ref>Siddiqui, S. & Siddiqui, R.H. (1931). Journal of the Indian Chemical Society, vol. 8, pp. 667-680.</ref> from the roots of [[Rauwolfia serpentina]]. He named it [[Ajmaline]], after [[Hakim Ajmal Khan]], one of the most illustrious practitioners of [[Unani|Unani system of medicine]] in South Asia.<ref name="sandilvi">Ahmed Nasim Sandilvi (2003), [http://www.dawn.com/weekly/science/archive/030412/science5.htm Salimuzzaman Siddiqui: pioneer of scientific research in Pakistan]. Daily Dawn. 12 April, 2003. Retrieved on 19 July, 2007.</ref> | ||
== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
{{Antiarrhythmic agents}} | {{Antiarrhythmic agents}} | ||
[[Category:Antiarrhythmic agents]] | [[Category:Antiarrhythmic agents]] | ||
[[Category:Drugs | [[Category:Cardiovascular Drugs]] | ||
[[Category:Drug]] | |||
[[ | |||
Latest revision as of 21:58, 23 July 2014
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C20H26N2O2 |
| Molar mass | 326.433 g/mol |
|
WikiDoc Resources for Ajmaline |
|
Articles |
|---|
|
Most recent articles on Ajmaline |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Ajmaline at Clinical Trials.gov Clinical Trials on Ajmaline at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Ajmaline
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Ajmaline Risk calculators and risk factors for Ajmaline
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Ajmaline |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ajmaline is a class Ia antiarrhythmic agent. It is often used to bring out typical findings of ST elevations in patients suspected of having Brugada syndrome.
The compound was first isolated by Salimuzzaman Siddiqui in 1931 [1] from the roots of Rauwolfia serpentina. He named it Ajmaline, after Hakim Ajmal Khan, one of the most illustrious practitioners of Unani system of medicine in South Asia.[2]
References
- ↑ Siddiqui, S. & Siddiqui, R.H. (1931). Journal of the Indian Chemical Society, vol. 8, pp. 667-680.
- ↑ Ahmed Nasim Sandilvi (2003), Salimuzzaman Siddiqui: pioneer of scientific research in Pakistan. Daily Dawn. 12 April, 2003. Retrieved on 19 July, 2007.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antiarrhythmic agents
- Cardiovascular Drugs
- Drug